ProShare Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.9K Sell
16,174
-5,275
-25% -$16.7K ﹤0.01% 1808
2025
Q4
$85.8K Buy
21,449
+1,381
+7% +$7.68K ﹤0.01% 1894
2025
Q3
$170K Sell
20,068
-3,998
-17% -$38.8K ﹤0.01% 1734
2025
Q2
$271K Sell
24,066
-925
-4% -$8.5K ﹤0.01% 1518
2025
Q1
$237K Sell
24,991
-7,522
-23% -$76K ﹤0.01% 1571
2024
Q4
$366K Buy
32,513
+10,698
+49% +$188K ﹤0.01% 1482
2024
Q3
$617K Buy
21,815
+6,758
+45% +$174K ﹤0.01% 1016
2024
Q2
$288K Sell
15,057
-5,141
-25% -$131K ﹤0.01% 1316
2024
Q1
$662K Buy
20,198
+1,962
+11% +$62.6K ﹤0.01% 937
2023
Q4
$602K Buy
18,236
+3,924
+27% +$111K ﹤0.01% 936
2023
Q3
$390K Sell
14,312
-17
-0.1% -$473 ﹤0.01% 1049
2023
Q2
$434K Buy
14,329
+4,680
+49% +$151K ﹤0.01% 1034
2023
Q1
$313K Sell
9,649
-900
-9% -$28.5K ﹤0.01% 1191
2022
Q4
$296K Buy
10,549
+1,512
+17% +$43.3K ﹤0.01% 1240
2022
Q3
$324K Sell
9,037
-172
-2% -$6.06K ﹤0.01% 1104
2022
Q2
$283K Sell
9,209
-5,746
-38% -$167K ﹤0.01% 1247
2022
Q1
$483K Sell
14,955
-2,458
-14% -$64.4K ﹤0.01% 1296
2021
Q4
$481K Buy
17,413
+7,480
+75% +$215K ﹤0.01% 1478
2021
Q3
$308K Sell
9,933
-10,177
-51% -$244K ﹤0.01% 1525
2021
Q2
$425K Sell
20,110
-66
-0.3% -$1.32K ﹤0.01% 1646
2021
Q1
$408K Buy
20,176
+3,451
+21% +$65.6K ﹤0.01% 1580
2020
Q4
$268K Buy
+16,725
New +$221K ﹤0.01% 1679
2020
Q3
Sell
-10,261
Closed -$73K 1659
2020
Q2
$73K Buy
+10,261
New +$68.7K ﹤0.01% 1606
2020
Q1
Sell
-10,042
Closed -$91K 1301
2019
Q4
$91K Buy
+10,042
New +$81.6K ﹤0.01% 1703
2018
Q4
Sell
-8,339
Closed -$237K 1617
2018
Q3
$237K Buy
+8,339
New +$199K ﹤0.01% 1492

Other funds holding EVH